# IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS

Study · id `cardio:ct-nct07796412` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07796412](<https://clinicaltrials.gov/study/NCT07796412>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07796412

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07796412. Randomized; single masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07796412, source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)
- Planned start: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT07796412, source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07796412, source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)
- Completion: 2029-01-30 (anticipated) (ClinicalTrials.gov record NCT07796412, source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07796412, source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07796412-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
- Acronym: IVUS-SCB
- Condition: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
- Intervention (Device): IVUS-Guided Sirolimus-Coated Balloon
- Intervention (Device): IVUS-Guided Sirolimus-Eluting Stent
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV
- Collaborator: B. Braun Medical International Trading Company Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)
- Registry lists this organization as a collaborator: B. Braun Medical International Trading Company Ltd. (`cardio:org-b-braun-medical-international-trading-company-ltd`)

## Provenance

Content hash: c66741ad4cd7fd0a018d4ac7c08d5320f9d2ec51fa582553d6ab8e6c832a9059
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
